- Locations
- New Patient Appointments
About Me
I am a medical oncologist whose practice is focused on caring for people with lung cancer. I have particular expertise in identifying patients who may benefit from immunotherapy or targeted therapy and incorporating these advanced therapies into their treatment plans. I am also actively involved in clinical trials to find newer and better ways to treat lung cancer.
People with lung cancer are often concerned with how their treatment will impact their day-to-day life. At MSK, our multidisciplinary team of experts is focused on effectively treating our patients’ disease in a way that helps them keep doing the things they love. Using the most advanced therapies in the field, we work together to design treatment plans that minimize side effects to make sure this can happen.
See My Colleagues
Publications
Arbour KC, Jordan E, Kim HR, Dienstag J, Yu HA, Sanchez-Vega F, Lito P, Berger M, Solit DB, Hellmann M, Kris MG, Rudin CM, Ni A, Arcila M, Ladanyi M, Riely GJ. Effects of Co-occurring Genomic Alterations on Outcomes in Patients with KRAS-Mutant Non-Small Cell Lung Cancer. Clin Cancer Res. 2018 Jan 15;24(2):334-340. doi: 10.1158/1078-0432.CCR-17-1841. Epub 2017 Oct 31.
Clinical Trials
Research is integral to our mission at Memorial Sloan Kettering, and clinical trials help us discover better forms of patient care and treatment. For you, this could mean access to a new therapy or therapy combination. Click to see a list of the trials I’m currently leading.
Clinical Trials Led by Kathryn C. Arbour
Clinical Trials Co-Investigated by Kathryn C. Arbour
Insurance
Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicare and New York State Medicaid also provide benefits for care at MSK.
Learn more
